Medical Practice Valuation Multiples by Specialty (2026)

By Carlo Ronci · Sell-Side Representation & Valuations, Tenet M&A

One of the most common questions physicians ask is what medical practice valuation multiples actually look like — what similar practices sell for, and where their own practice might land. This guide compiles typical EBITDA and SDE multiple ranges by specialty, size, and buyer type into a single reference, and explains what moves a practice up or down within those ranges. Use it to calibrate expectations before you talk to buyers — then get a real, healthcare-specific number rather than relying on a rule of thumb.

For the mechanics behind these numbers, read our complete guide to medical practice valuation. When you are ready for a rigorous figure, Tenet M&A provides confidential valuations as part of how we help physicians sell a medical practice.

How medical practice valuation multiples work

A valuation multiple is simply the number you multiply a practice’s normalized earnings by to reach its enterprise value. For most profitable practices, that earnings figure is Adjusted EBITDA — earnings before interest, taxes, depreciation, and amortization, normalized for owner-specific and one-time expenses. Smaller, owner-operated practices are often valued on Seller’s Discretionary Earnings (SDE), which adds the owner’s salary back to earnings. Getting these add-backs right often changes the final price more than the multiple itself — see the role of EBITDA in valuation.

Two forces set the multiple: the practice’s own risk and growth profile, and how many buyers are competing for it. That is why the ranges below are wide — and why a practice at the top of its range can be worth nearly double one at the bottom with identical revenue.

Valuation multiples by practice size

Size is the single biggest driver of the multiple, because larger practices carry less risk, more infrastructure, and less dependence on any one physician. As earnings grow, the multiple typically expands — a dynamic buyers call the “size premium.”

Ranges are broad, educational estimates for illustration only; actual multiples vary widely by specialty, market, and deal terms. See how practice size influences deals.

Valuation multiples by specialty

Specialty matters because it shapes buyer demand, payer mix, ancillary revenue, and how “rollable” a practice is into a larger platform. Specialties with strong private-equity consolidation and ancillary income tend to command higher multiples; those more dependent on a single physician or on unfavorable reimbursement tend toward the lower end. The ranges below assume an established, reasonably sized group — a small solo practice in any specialty will typically sit below its range.

Illustrative ranges for educational use only, not an appraisal or an offer. Individual practices routinely fall outside these ranges. Explore all specialties on our who we serve page.

How buyer type changes the multiple

Who buys your practice can matter as much as what you sell. The same practice can attract very different multiples depending on the buyer’s strategy:

• Private-equity platforms and MSOs/DSOs often pay the highest multiples for practices that fit a roll-up, because they can add scale and resell at a larger platform multiple — see selling to private equity.
• Hospitals and health systems value strategic fit, referrals, and coverage, and may pay well for the right practice in the right market.
• Individual physician buyers typically pay lower multiples and rely on financing, but can be the best cultural fit for a smaller practice or internal succession.

Running a competitive process across multiple buyer types is often the single most effective way to move from the bottom of a range to the top. That is the core of what a sell-side advisor does.

What moves your practice within the range

The specialty and size set the range; your fundamentals decide where you land in it. Factors that push toward the top:

• Consistent revenue and patient-volume growth
• Associate providers who reduce dependence on the selling physician
• A diversified payer and referral base
• Ancillary and cash-pay revenue streams
• Clean financials, modern systems, and secure leases and staffing

The factors that pull toward the bottom are the mirror image — owner dependence, declining volume, payer concentration, and deferred investment. Most are improvable in the 12–36 months before a sale; see what drives higher or lower valuations and what buyers value most.

How the 2026 market affects multiples

Multiples are not fixed to a practice — they breathe with the market. When financing is cheap and buyer appetite is high, multiples expand; when rates rise, buyers grow selective and multiples can compress. Healthcare has remained one of the most active consolidation sectors, but the cost of capital and each specialty’s consolidation stage both shape today’s numbers. Timing your sale to your own readiness and the market backdrop can meaningfully change the outcome — read the effect of interest rates on valuations.

Why a benchmark is a starting point, not an answer

Medical practice valuation multiples are useful for calibration, but dangerous as a substitute for a real valuation. A multiple applied to the wrong earnings figure — or to a practice at the wrong end of its range — produces a number that feels precise and is simply wrong. Owners who anchor to a rule of thumb routinely leave money on the table or hold out for a figure the market will never support. Understand the difference between an appraisal, an opinion of value, and market value before you rely on any figure.

Get a real number for your practice

Tenet M&A delivers confidential, healthcare-specific valuations built on your normalized financials, your specialty’s real transaction data, and today’s buyer landscape — not a formula. We show you not only a number but the drivers behind it and the specific steps that could move you up your range before you go to market. Explore our advisory services or start a confidential conversation. There is no cost to explore your options; this guide is educational and is not tax, legal, or investment advice.

Frequently asked questions about medical practice valuation multiples

What multiple do medical practices sell for?

There is no single multiple. Small solo practices often sell for roughly 2–4× SDE, established groups for about 4–6× Adjusted EBITDA, and larger multi-provider or platform-scale groups for 6–8× or more when private-equity buyers compete. Specialty, growth, payer mix, and buyer type all shift the number.

Which medical specialties command the highest valuation multiples?

Specialties with heavy private-equity consolidation and strong ancillary or cash-pay revenue — such as dermatology, ophthalmology, and gastroenterology — tend toward the higher end, while smaller or single-physician-dependent practices tend toward the lower end. Size and fundamentals still matter more than specialty alone.

What is the difference between an EBITDA multiple and an SDE multiple?

SDE (Seller’s Discretionary Earnings) adds the owner’s salary back to earnings and is used for smaller, owner-operated practices; EBITDA is used for larger practices with management in place. Because the earnings bases differ, their multiples are not directly comparable.

Do private-equity buyers pay higher multiples?

Often, yes — for practices that fit a roll-up strategy. PE platforms and MSOs/DSOs can pay premium multiples because they add scale and resell at a larger platform multiple. The best outcome usually comes from putting several buyer types in competition.

How accurate are valuation multiple benchmarks?

Benchmarks are directional, not definitive. They calibrate expectations but cannot account for your specific financials, add-backs, market, and buyer demand. A specialty-specific valuation is the only reliable way to know what your practice is worth.